Back to top

Omnicell Inc: (OMCL)

(Delayed quote from: NSDQ) As of Sep 17, 2014 03:59 PM ET

 Add to portfolio

 ZacksTrade Now

$26.64 USD

26.64

+0.25 (0.95%)

Volume: 131,181

Zacks Rank : 2-Buy [?]   2      

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1 Strong Buy 26.65%
2 Buy 18.84%
3 Hold 10.45%
4 Sell 4.76%
5 Strong Sell 2.56%
S&P 500 10.28%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The way to access to the Zacks Rank

Company Summary

Omnicell Inc., provides clinical infrastructure and workflow automation solutions that enable healthcare facilities to acquire, manage, dispense, and deliver medications and supplies more effectively and efficiently.

General Information

OMNICELL INC

590 E. MIDDLEFIELD ROAD

MOUNTAIN VIEW, CA 94043

Phone: 650-251-6100

Fax: 650-251-6266

Web: http://www.omnicell.com

Email: ir@omnicell.com

Industry MEDICAL INFO SYSTEMS
Sector Medical
Fiscal Year End December
Last Reported Quarter 6/30/2014
Next EPS Date 10/30/2014

EPS Information

Current Quarter EPS Consensus Estimate 0.23
Current Year EPS Consensus Estimate 0.92
Estimated Long-Term EPS Growth Rate 19.30
Next EPS Report Date 10/30/2014

Price and Volume Information

Zacks Rank
Yesterday's Close 26.39
52 Week High 30.33
52 Week Low 20.88
Beta 0.90
20 Day Moving Average 141,349.05
Target Price Consensus 31.40

OMCL

% Price Change
4 Week -5.11
12 Week -5.24
YTD 3.72
% Price Change Relative to S&P 500
4 Week -5.93
12 Week -7.57
YTD -3.38
Share Information
Shares Outstanding (millions) 35.87
Market Capitalization (millions) 946.69
Short Ratio 3.23
Last Split Date NA
Dividend Information
Dividend Yield 0.00%
Annual Dividend $0.00
Payout Ratio 0.00
Change in Payout Ratio 0.00
Last Dividend Payout / Amount NA / $0.00

Fundamental Ratios

P/E
P/E (F1) 28.84
Trailing 12 Months 29.65
PEG Ratio 1.50
EPS Growth
vs. Previous Year 31.58%
vs. Previous Quarter 31.58%
   
Sales Growth
vs. Previous Year 12.13%
vs. Previous Quarter 3.23%
   
Price Ratios
Price/Book 2.56
Price/Cash Flow 20.50
Price / Sales 2.33
ROE
6/30/14 8.95
3/31/14 8.51
12/31/13 7.76
ROA
6/30/14 6.34
3/31/14 6.04
12/31/13 5.48
Current Ratio
6/30/14 2.67
3/31/14 2.72
12/31/13 2.53
Quick Ratio
6/30/14 2.37
3/31/14 2.39
12/31/13 2.19
Operating Margin
6/30/14 7.98
3/31/14 7.56
12/31/13 6.94
Net Margin
6/30/14 7.02
3/31/14 6.78
12/31/13 6.30
Pre-Tax Margin
6/30/14 10.79
3/31/14 10.31
12/31/13 9.20
Book Value
6/30/14 10.32
3/31/14 10.04
12/31/13 9.80
Inventory Turnover
6/30/14 6.01
3/31/14 6.12
12/31/13 6.18
Debt-to-Equity
6/30/14 0.00
3/31/14 0.00
12/31/13 0.00
Debt to Capital
6/30/14 0.00
3/31/14 0.00
12/31/13 0.00